In 2023, the primary market started off slowly, but it gained significant momentum as the new financial year kicked off in April 2023.
And as markets started to go up. Companies like to come out with their public offers when the sentiment in overall market is good.
In recent two weeks, the primary market has become a hive of activity with numerous new public offerings, and this trend is only gaining strength.
Many of these IPOs have delivered impressive double-digit returns, some even soaring as high as 106% since their listing dates.
Looking ahead, the second half of the financial year 2024 is expected to see the launch of IPOs by at least 71 companies.
Among the highly anticipated upcoming offerings, EMS kicked off its IPO this week.
Here are the key details of the IPO.
Issue period: 8 September 2023 to 12 September 2023
Type of issue: Book Built Issue
Price band: Rs 200 to Rs 211 per share
Face value: Rs 10 per equity share
Lot size: 70 shares
Application limit: Maximum thirteen lot for retail investors. Retail investors can make an application for a minimum of Rs 14,770 for one lot (70 shares) and their maximum investment would be Rs 192,010 (910 shares).
Tentative IPO allotment date: 18 September 2023
Tentative listing date: 21 September 2023
EMS previously known as EMS Infracon, is engaged in the business of providing water and wastewater collection, treatment, and disposal services.
The company provides complete, single-source services from engineering and design to construction and installation of water, wastewater, and domestic waste treatment facilities.
The company provides water supply and waste treatment systems, electrical distribution, road construction, and maintenance services. These services are primarily focused on government wastewater and water supply projects.
The company's revenue has grown at a CAGR of 16.7% in the last three years, while the net profit of the company grew at a CAGR of 14.7%.
This was due to the increase in government projects and decrease in operating expenses over time.
For the financial year 2023, the company reported a 50% YoY jump in revenue to Rs 5.4 bn. This is primarily due to increasing income from the installation of sewerage treatment plants.
The net profit also reported a net profit of Rs 1,086.7 m, up 37.6% from the net profit of Rs 789.3 m reported a year back.
Particulars | 31-Mar-21 | 31-Mar-22 | 31-Mar-23 |
---|---|---|---|
Revenues (Rs in bn) | 3.4 | 3.6 | 5.4 |
Revenue Growth (%) | 1.1 | 5.9 | 50.0 |
Net Profit (Rs in m) | 719.1 | 789.3 | 1,086.7 |
Net Worth (Rs in bn) | 3.0 | 3.8 | 4.9 |
Going forward, the company's goal is to enhance its income by capitalising on the increasing prevalence of non-communicable diseases (NCDs) and the growing medical tourism industry in India, which will contribute to its further expansion.
As per the company's red herring prospectus, the following is industry peer of EMS.
Company | Total Income (2023) (Rs in bn) |
EPS (Basic) (in Rs) | Return on Net Worth (%) |
---|---|---|---|
EMS | 5.4 | 23.2 | 22.3 |
VA Tech Wabag | 30.1 | 36.9 | 0.7 |
In recent years, the Indian government has launched a series of initiatives aimed at enhancing the country's water supply and sewage infrastructure.
Notable programs include JJM, Jal Shakti, and Atal Bhujal Yojana, all of which have been rolled out within the past seven years.
Looking forward, the company has formulated a strategic plan to expand its footprint in Western markets.
This expansion is expected to receive significant support from government initiatives such as the Pradhan Mantri Jan Arogya Yojana (PMJAY), reflecting the government's growing emphasis on the healthcare sector.
Additionally, the company anticipates a surge in power demand in the future, driven by population growth and increased economic activity.
The government has taken proactive steps by implementing a Revamped Distribution Scheme with a substantial budget allocation of Rs 3,040 bn over a five-year period spanning from FY22 to FY26.
This initiative is poised to further enhance the company's performance and opportunities in the energy sector.
Like any investment opportunity, EMS bears its own set of advantages and disadvantages. Therefore, one should conduct thorough research.
For more information on IPOs, check out the list of upcoming IPO's.
Lithium is the new oil. It is the key component of electric batteries.
There is a huge demand for electric batteries coming from the EV industry, large data centres, telecom companies, railways, power grid companies, and many other places.
So, in the coming years and decades, we could possibly see a sharp rally in the stocks of electric battery making companies.
If you're an investor, then you simply cannot ignore this opportunity.
Details of our SEBI Research Analyst registration are mentioned on our website - www.equitymaster.comDisclaimer: This article is for information purposes only. It is not a stock recommendation and should not be treated as such. Learn more about our recommendation services here...
As per Equitymaster's Stock Screener, these are the best performing IPO stocks right now -
These companies have been ranked as per the gains they have delivered to investors since listing.
Remember, it's not easy to identify future multibagger stocks, but if you do it carefully and with due diligence, you can find high growth companies which can turn out to become future multibaggers.
The best performing IPOs have already delivered outsized returns. So there is a good chance these stocks might be overpriced.
Before you invest your hard-earned money, make sure you check out the valuations first. Studying the business is equally important. One should only invest in fundamentally strong stocks with bright prospects.
GMP stands for grey market premium. It is the amount, over and above the issue price, that traders are willing to pay or ask for to trade IPO shares. The GMP can tell you how an IPO will perform on its listing day.
If you are applying for an IPO, take a look to see what could happen on listing day. But remember GMP shouldn't be the only factor influencing your decision on whether or not to hold or exit the stock.
If you are an investor, then we would say take the GMP with a pinch of salt. A factor as volatile as GMP can't be a deciding factor.
Therefore, you should never apply for an IPO just because it commands a good GMP. You should apply for an IPO because you believe in the company's earning potential. Hence more weightage should be given to the fundamentals of the company.
IPO Price Band is the price range within which investors can bid for the shares. The minimum price is called the floor price and the maximum price is called the cap price.
In case the company revises the price band, the offer period gets extended for at least three additional working days.
Any revision in the price band and the revised offer period, if applicable, is shared by notification to the stock exchanges by issuing a press release and on the websites of the book running lead managers.
Equitymaster requests your view! Post a comment on "EMS IPO: 5 Things to Know". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!